Home > Investor > Financial Highlights > Revenues by country

Revenues by country

Distribution of sales revenues by geographic region 
 %
Europe 27
Bulgaria  71
Other 2

The contribution of sales in Bulgaria to the consolidated sales revenue in 2015 amounted to 71%, increasing by 6% compared to 214. Sopharma had a 4% share of the Bulgarian pharmaceutical market in terms of value and a 14% share in term of sold quantity (units). The position of the main competitors of the Company in the country are as follows:

  • Novartis: 7% (4% in units)
  • Roche: 6% (0.3% in units),
  • GlaxoSmithKlein: 6% (3% in units)
  • Actavis: 4.8 % (12% in units)
  • Sanofi-Aventis: 4.3% (3% in units)
  • Astra Zeneca: 3.3% (0.9% in units)
  • Bayer: 2% (1.9 in units)